Clinical Trial Update: Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Cystadrops in pediatric cystinosis patients aged six months to less than two years completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystinosis

Drugs mentioned

• Cystadrops (mercaptamine hydrochloride)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Cystinosis | Phase 3 | Status: COMPLETED